US and UK IPOs, read point by point
What to read closely in each listing document, with its own words and page. No tips, no ratings.
Indian IPOs: Review DRHPs
One review, in pictures
Open the full review →Latest reviews
Every Monday: our new US, UK and Indian reviews, what opens and what closed, each with its key point and page. Free; unsubscribe with one click.
This week
IPOs we track with a date in the next three weeks, then what happened in the last seven days. Italic dates are expected.
United States · Nasdaq and NYSE
All US IPOs by date →| Company | Exchange | Dates | Review |
|---|---|---|---|
| Bitari Inc. BIAI Awaiting confirmation | Nasdaq | Registration effective: 29 Oct 2026 Trading expected: w/c 2 Nov 2026 | Not reviewed |
| Aspen Neuroscience, Inc. ASPE Awaiting confirmation | Nasdaq | Registration effective: 29 Oct 2026 Priced: 30 Oct 2026 Trading expected: 30 Oct 2026 | Not reviewed |
| Bambusa Therapeutics, Inc. BBTX Awaiting confirmation | Nasdaq | Registration effective: 29 Oct 2026 Priced: 30 Oct 2026 Trading expected: 30 Oct 2026 | Not reviewed |
| OPay Limited (ADSs) OPAY Awaiting confirmation | NYSE | Registration effective: 29 Oct 2026 Trading expected: 30 Oct 2026 | Not reviewed |
United Kingdom · Main Market and AIM
All UK IPOs by date →| Company | Exchange | Dates | Review |
|---|---|---|---|
| Abenojar Tungsten SA ABT Awaiting confirmation | Main Market | Priced: 27 Oct 2026 Conditional dealings expected: 27 Oct 2026 Admission expected: 30 Oct 2026 | Not reviewed |
How each review is made. The same engine reads every document with a rulebook for its market. Code finds every quote again on its page and checks the document's own figures against each other; fixed rules rate each check. An independent reviewer checks every point against the document before publication.
What this is not. Information from the documents, not investment advice: no view on the price and no recommendation to buy or sell.